symbicort turbuhaler
astrazeneca ab - budezonidas/formoterolio fumaratas dihidratas - įkvepiamieji milteliai - 160 µg/4,5 µg/išpurškime; 320 µg/9 µg/dozėje; 160 µg/4,5 µg/dozėje; 80 µg/4,5 µg/dozėje - formoterol and budesonide
symbicort
astrazeneca ab - budezonidas/formoterolio fumaratas dihidratas - suslėgtoji įkvepiamoji suspensija - 80 µg/2,25 µg/išpurškime - formoterol and budesonide
beyfortus
astrazeneca ab - nirsevimab - imuninės serumai ir imunoglobulinai, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.
plendil
astrazeneca ab - felodipinas - pailginto atpalaidavimo tabletės - 10 mg; 2,5 mg - felodipine
imfinzi
astrazeneca ab - durvalumab - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).
zomig
astrazeneca uk limited - zolmitriptanas - plėvele dengtos tabletės - 2,5 mg - zolmitriptan
qtern
astra zeneca ab - saxagliptin, dapagliflozin propandiolis monohidratas - diabetes mellitus, type 2; diabetes mellitus; nutritional and metabolic diseases; metabolic diseases; glucose metabolism disorders - narkotikai, vartojami diabetu - qtern, fiksuotų dozių derinys saxagliptin ir dapagliflozin, yra nurodyta suaugusiems žmonėms nuo 18 metų ir vyresni, su 2 tipo cukrinis diabetas:gerinti glycaemic kontrolės, kai metforminas ir (arba) sulfonilkarbamido dariniai (Šu) ir viena monocomponents, qtern nesuteikia pakankamos glycaemic kontrolės,kai jau gydomi nemokamai derinys dapagliflozin ir saxagliptin. (Žr. skirsnius 4. 2, 4. 4, 4. 5 ir 5. 1 duomenys apie derinius studijavo.
nexium
actiofarma, uab - ezomeprazolas - skrandyje neirios tabletės - 20 mg - esomeprazole
seroquel xr
astrazeneca uk limited - kvetiapinas - pailginto atpalaidavimo tabletės - 150 mg; 400 mg; 200 mg; 50 mg; 300 mg - quetiapine
seroquel
astrazeneca uk limited - kvetiapinas - plėvele dengtos tabletės - 25 mg + 100 mg + 200 mg; 200 mg - quetiapine